ABSTRACT The neurotropic herpesvirus varicella-zoster virus (VZV) establishes a lifelong latent infection in humans following primary infection. The low abundance of VZV nucleic acids in human neurons has hindered an understanding of the mechanisms that regulate viral gene transcription during latency. To overcome this critical barrier, we optimized a targeted capture protocol to enrich VZV DNA and cDNA prior to whole-genome/transcriptome sequence analysis. Since the VZV genome is remarkably stable, it was surprising to detect that VZV32, a VZV laboratory strain with no discernible growth defect in tissue culture, contained a 2,158-bp deletion in open reading frame (ORF) 12. Consequently, ORF 12 and 13 protein expression was abolished and Akt phosphorylation was inhibited. The discovery of the ORF 12 deletion, revealed through targeted genome sequencing analysis, points to the need to authenticate the VZV genome when the virus is propagated in tissue culture.
IMPORTANCE Viruses isolated from clinical samples often undergo genetic modifications when cultured in the laboratory. Historically, VZV is among the most genetically stable herpesviruses, a notion supported by more than 60 complete genome sequences from multiple isolates and following multiple in vitro passages. However, application of enrichment protocols to targeted genome sequencing revealed the unexpected deletion of a significant portion of VZV ORF 12 following propagation in cultured human fibroblast cells. While the enrichment protocol did not introduce bias in either the virus genome or transcriptome, the findings indicate the need for authentication of VZV by sequencing when the virus is propagated in tissue culture.
KEYWORDS ORF 12, VZV, deletion, genome, transcriptome V aricella-zoster virus (VZV) is a ubiquitous neurotropic human alphaherpesvirus. Serological studies show that over 95% of the world's population is exposed to the virus (1). VZV is typically acquired early in life, thereafter establishing latency in multiple cranial and dorsal root ganglia (2) as well as thoracic sympathetic (3) and enteric (4) ganglia. With declining cell-mediated immunity to VZV due to aging, disease, or immunosuppressive therapy, the virus can reactivate to produce zoster (5), which is often complicated by persistent, dermatomal distribution pain (postherpetic neuralgia), the leading cause of pain-related suicide in elderly patients (6) . Zoster increases the risk of stroke 2.4-fold and of myocardial infarction 1.7-fold within 2 weeks of onset (7) , and the risk remains elevated for the subsequent 3 months (8) . Furthermore, VZV reactivation is associated with giant cell arteritis, the most common systemic vasculitis in the elderly (9) . The successful treatment of an immunocompetent patient with 6 years of chronic progressive neurological disease attributed to VZV infection of the brain (10) highlights the protean nature of VZV infections (11) .
A critical barrier to the study of VZV latency is the low virus burden in naturally infected human ganglia removed at autopsy (12) and in experimentally infected human neurons maintained in tissue culture (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . While protocols to enrich VZV DNA (23) and cDNA (24) relative to host nucleic acids have been developed, the sensitivity and specificity provided by PCR reaffirms the benefit of this technology for investigations into latent VZV gene transcription and its regulation (25) (26) (27) (28) . However, extending PCR technologies to virus whole-genome analysis requires multiple optimizations and recalibrations to maintain primer efficiency in multiplex reactions involving Ͼ20 individual amplicons (29) .
The VZV genome is remarkably stable. The complete genome sequence of 66 VZV isolates is publically available (http://www.ncbi.nlm.nih.gov/nuccore/?termϭvaricellaϩ zosterϩvirusϩcompleteϩgenome), and the 124,947-Ϯ 210-bp DNA can be partitioned into 5 defined clades (30) , with the possible emergence of a 6th clade (31) . While new VZV isolates can be genotyped by single-nucleotide polymorphism (SNP) analysis within VZV open reading frames (ORFs) 21 and 50 (32) , VZV clades are genetic variations that are informative for epidemiology (33) (34) (35) (36) and evolutionary studies (37-40) but do not describe different virus phenotypes in the human population. Naturally circulating VZV can undergo limited recombination (31, 41) , but the only phenotypic mutation identified to date in clinical isolates is the D150N SNP in glycoprotein E, which results in increased virus spread in cell culture (42) .
VZV DNA is stable, with no detectable mutation during 16 passages in vitro after clinical isolation (33) . A total of 72 in vitro passages of the VZV32 strain introduced 31 SNPs, resulting in one codon change in ORF 33 (viral protease) and 6 codon changes in the major immediate-early transcriptional transactivating protein (IE62) encoded by VZV ORF 62, but these mutations did not hinder virus growth in culture (43) . The 834-bp VZV ORF 63 encoding immediate-early protein 63 (IE63) is stable, and only 3 SNPs arose in ORF 63 between in vitro passages 1,060 and 1,206, none of which affected IE63 size, immunoreactivity on Western blots, or virus growth characteristics in culture (44) . Based on the documented stability of VZV DNA in the human population and in tissue culture, we developed methods to enrich VZV sequences from a background of host nucleic acid and found an unexpected 2,158-bp deletion in ORF 12 of a VZV laboratory strain with no discernible growth defect in tissue culture. This novel feature was discovered only through targeted genome sequencing analysis, underscoring the need to authenticate the VZV genome when the virus is propagated in tissue culture.
RESULTS
Library construction and efficiency of virus nucleic acid enrichment. Illumina sequencing libraries were constructed from total DNA or RNA extracted from biological replicates of VZV-DEN09-infected human fetal lung fibroblast (HFL) cells and sequenced pre-and postenrichment for virus nucleic acids. Infected cells were harvested 2 days after low-multiplicity infection to ensure the presence of the full virus transcriptome, as the virus propagated asynchronously (45) . FastQC analysis to assess DNA sequence quality for each library (data not shown) identified each nucleotide with a high degree of confidence (average per-base sequence quality score of Ͼ36) and no significant bias in GC content (absence of peaks in average per-base sequence content). Consequently, no end trimming of DNA sequences was required, and the entire 51-nucleotide sequence from 2.17 ϫ 10 8 individual sequencing events was analyzed.
To determine virus nucleic acid enrichment efficiency, sequenced reads were aligned to the reference VZV32 passage 72 (DQ479963.1) and human genome assembly 19 (https://genome.ucsc.edu/cgi-bin/hgGateway) ( Table 1) . On average, 97.6% of total reads mapped to either virus or human sequences. In unenriched libraries, 20.2% Ϯ 5.9% of DNA reads and 0.44% Ϯ 0.02% of cDNA reads mapped to the VZV sequence. After targeted enrichment, the proportion of reads mapping to VZV increased to 97.7% Ϯ 0.9% for DNA and 68.8% Ϯ 3.3% for cDNA. An inverse linear relationship existed between the initial abundance of virus nucleic acid present and the amount of target DNA enrichment (Fig. 1) , i.e., enrichment was greater with less virus nucleic acid. For example, 0.4% of total cDNA sequences mapped to the VZV genome in unenriched samples from VZV-infected HFL cells, while the amount of VZV cDNA sequences increased 162-Ϯ 5-fold after enrichment. On the other hand, the overall enrichment of virus DNA was low when initial target DNA was abundant. For example, 24.1% of total DNA mapped to the VZV genome in unenriched samples, while the amount of VZV DNA sequences increased only 4% after enrichment. Nonetheless, the vast majority of DNA sequences (Ͼ83%) obtained after targeted enrichment of VZV DNA and cDNA mapped to the virus. Table 3 , columns 8 to 11). VZV-DEN09 DNA extracted from infected cells was diluted to ϳ6,000 copies per PCR and amplified with the 8 sets of PCR primers. Results of 4 to 6 separate assays showed that areas A and C/C= contained 2.22-Ϯ 0.79-and 4.32-Ϯ 0.70-fold more DNA, respectively, than that detected using the six baseline primer sets (Table 3 , columns 12 to 15), confirming the increased presence of VZV DNA in these areas indicated by whole-genome sequencing.
To determine whether the overrepresented virus DNA in region A (Fig. 2 ) resulted from unanticipated DNA repeats present in VZV-DEN09 but not in VZV32, two independent samples of VZV-DEN09 DNA were PCR amplified in duplicate and compared to fragments from PCR of VZV BAC DNA extracted from E. coli (Fig. 3, left) . A predicted 2.7-kbp fragment was detected in all samples. To determine if new repeat regions were contained within the 2.7-kbp segment, the entire segment was Sanger sequenced using sets of internal primers (Fig. 3, right) . The DNA sequence for each PCR product showed that the 2,711 Ϯ 6 nucleotide fragment contained no repeated segment.
The deletion in area B results in the absence of ORF 12. The DNA deletion (area B) indicated by whole-genome sequencing was confirmed by PCR using primers located 79 and 49 nucleotides before and after the expected deletion site, respectively (Fig. 4 ). An ϳ2.3-kbp PCR band was present in VZV-DG, VZV-NASA, VZV Web A (RIT), VZV-DEN09, and VZV-DEN13 DNA samples (Fig. 4A) . While the 2.3-kbp DNA fragment was predicted in all complete VZV genome sequences publically available and was present in VZV-DEN09 at passage 7, albeit to a lesser extent, in HFL cells (lane 5), it was undetectable in VZV-DEN09 after 20 passages in HFL cells (lanes 6 to 8). Instead, an ϳ140-bp fragment was present in these samples and, to a lesser degree, in VZV-DEN13 after 2 passages in MRC-5 cells (lanes 9 and 10). The disappearance of the 2.3-kbp band Deep-Sequence Analysis of VZV DNA and Transcripts Journal of Virology and appearance of the ϳ140-bp PCR product was consistent with the targeted genome sequencing data for VZV-DEN09 after 20 passages in HFL cells ( Fig. 2 ) and suggested that a large deletion in VZV32 had occurred. DNA sequence analysis of the 140-bp PCR product in lane 6 confirmed the deletion of 2,160 bp from nucleotides 16269 to 18428 with respect to the VZV32 passage 72 genome (Fig. 4B ). The outcome of this deletion preserved the coding sequence for the first 22 amino acids of ORF 12 but removed the coding sequence for the remaining C-terminal 211 amino acids. Interestingly, the TAA termination codon that truncated ORF 12 was generated from a fusion of TAC (tyrosine codon) of ORF 12 with the ATG (initiation codon) of ORF 13 ( Fig. 4B) . Therefore, we asked if the DNA deletion in VZV-DEN09 affected the protein expression of ORFs 12 and 13. MeWo, HFL, and quiescent human brain vascular adventitia fibroblast (HBVAF) cultures were infected with VZV-DEN09 and VZV-DEN13 for 72 h, and infection efficiency was quantitated by glycoprotein E (gE) expression (Fig. 5A to D) . Expression of ORFs 12 and 13 then was examined by immunoblotting. In all three cell types, only infection with VZV-DEN13 supported expression of ORFs 12 and 13 ( Fig. 5E ). Since ORF 12 protein triggers phosphorylation of Akt (46), we also examined whether infection with VZV-DEN09 would phosphorylate Akt through a possible ORF 12-independent, redundant pathway. HBVAFs were included as a control because quiescence has previously been established in these cells (47) , which allows background levels of phosphorylated Akt to be kept at a minimum (46, 48) . Total Akt protein expression was similar in uninfected and infected cells. However, while VZV-DEN13 infection induced Akt phosphorylation, no phosphorylated Akt was detected following VZV-DEN09 infection (Fig. 5E) .
The ORF 12 deletion has minimal influence on VZV replication. We examined if loss of ORF 12 and ORF 13 proteins could influence virus replication in the cell types in 
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which the viruses were grown. While a minor, yet significant, decrease in replication was observed with VZV-DEN09 infection of MeWo cells at 4 dpi, infection of HFL cells with VZV-DEN09 and VZV-DEN13 did not result in any discernible replication differences (Fig. 6) . Analysis of DNA sequence bias in enriched virus samples. To determine whether DNA enrichment was uniform across the virus genome, the VZV-DEN09 cpn at each nucleotide location was normalized and compared before and after DNA enrichment. For each library, the cpn for the ith nucleotide was modified to reflect the read originated from a 51-bp DNA sequence by summing the cpn for each position 25 nucleotides before and after the ith position. For each nucleotide, the new cpn was divided by the maximum cpn for all positions, resulting in a normalized cpn for each position ranging from 0 to 1. The normalized cpn for each enriched library was then divided by the normalized cpn for each unenriched library, converted to log 2 values, and averaged for each position across all library combinations. The resulting bias value reflected whether specific DNA sequences were overrepresented due to the postenrichment 14 PCR cycles (bias value, Ͼ1) or to the loss of specific DNA sequences during target enrichment (bias value, Ͻ1). The overall average bias value was Ϫ0.18 Ϯ 0.23, suggesting a slight, but insignificant, negative bias during enrichment. Display of the bias value for each nucleotide (Fig. 7) indicated that the only area of VZV DNA showing a bias value of Ͻ1 was the deletion identified as region B in Fig. 2 . No bias of Ͼ2-fold was encountered during enrichment of VZV DNA across the VZV genome.
VZV-DEN09 transcriptome. Directional cDNA libraries were constructed from total RNA extracted from biological replicates of VZV-infected HFL cells (Table 1 , samples C and D). After sequencing, reads for each library (with or without enrichment) were aligned to specific strands of the 123,025-bp VZV-DEN09 genome assembled from DNA sequence data obtained as described above (Table S3 ). For each library, the total number of reads divided by total cpn for each strand indicated a read length of 50.9 Ϯ 0.2 nucleotides, verifying the integrity of alignment and mapping data.
To determine whether cDNA enrichment was uniform for all nucleotides across the VZV genome, a bias value similar to that described above was determined. A total of 1.22 ϫ 10 8 cpn were obtained, but each library was trimmed to omit Ͻ10 cpn for unenriched libraries and Ͻ100 cpn for enriched libraries, yielding 1.10 ϫ 10 8 cpn used for further calculations. For each VZV DNA nucleotide, the trimmed cpn was normalized to the maximum cpn of the related DNA strand. The bias value plot (quotient of normalized enriched samples to normalized unenriched samples) showed the deviation from expectation (bias value, 0) for each nucleotide (Fig. 8) . A total of 73,867,869 cpn mapped to the top strand of the virus genome, while 47,668,602 cpn mapped to the bottom DNA strand, showing 1.55:1 top-to-bottom virus strand coding usage. For both DNA strands, the majority of cpn (90.5% [top] and 88.7% [bottom]) showed bias values between Ϫ1 and ϩ1, indicating a Ͻ2-fold relative difference between unenriched and enriched VZV cDNA. Bias values of ϽϪ1 were obtained for 3.1% of nucleotides on the top strand and 4.5% of nucleotides on the bottom strand of the virus genome, indicating a Ͼ2-fold relative enrichment of cDNA at these locations. Bias values of Ͼ1 were obtained for 6.4% of nucleotides on the top strand and 6.9% of nucleotides on the bottom strand, indicating a Ͼ2-fold enrichment of cDNA at these locations. Since cpn reflects alignment of 51-bp sequencing reads, a 51-bp sliding window was generated to map individual cpn to reads. Of the 9,435 nucleotides showing Ͼ2-fold (absolute value) bias values, only 82 (0.9%) mapped to potential sequencing reads. To determine whether these 82 reads were located within coding regions, the VZV-DEN09 genome was annotated based on the archived VZV32 passage 72 genome (accession no. DQ479963). While coding frames were shifted for some ORFs due to intergenic indels, only the ORF 12 truncation showed a length difference compared to the archived genome (Fig. 9) . Based on the VZV-DEN09 annotation, the 5= end of the outlying transcriptome sequencing (RNA-seq) reads were located at nucleotides 36283 (ORF 22), 60098 to 60095 (ORF 33), 119227 to 119246, and 119876 to 119894 (ORF 71). Analysis of transcripts per million mapped reads, calculated by normalizing the sum of cpn for each VZV-DEN09 ORF to ORF length followed by renormalization to total cpn, all divided by 10 6 , revealed no significant difference (P ϭ 0.11 to 0.99 by t test) between the two independent unenriched libraries and enriched libraries at any of the 74 VZV ORFs (Table S4 ), indicating that targeted enrichment of VZV cDNA did not alter the transcriptional profile of the annotated VZV genes. An asterisk denotes 0% of mock-infected cells expressed VZV gE ϩ . (E) Cell lysates were prepared for immunoblotting and resolved on 12.5% SDS-PAGE gels. Membranes were probed for ORFs 12 and 13 and total and phospho-Akt. gE was included as an infection control, and ␤-actin was included as a loading control. 
Deep-Sequence Analysis of VZV DNA and Transcripts
Journal of Virology Summation of strand-specific cpn for all libraries of VZV-DEN09 was used to develop a transcriptome map (Fig. 10) . All annotated VZV ORFs were transcribed in HFL cells, and their steady-state abundance was ranked in order of decreasing amounts (Table 4) . To better determine relationships between transcript abundance, VZV genes were grouped into similar temporal and functional groups based on established or predicted homology to herpes simplex virus 1 (HSV-1). The average rank for VZV genes sorted into temporal classes was immediate early (8. 
DISCUSSION
Despite its global distribution and an extremely long evolutionary history, VZV DNA is remarkably homogeneous throughout the world. The VZV mutation rate of 1 ϫ 10 Ϫ5 to 6 ϫ 10 Ϫ5 substitutions/site/year translates into Ͻ1 mutation in the 125-kbp genome per year (35) . The VZV phenotype is even more stable; the only reported clinical strain of VZV with an altered in vitro growth phenotype has a nonsynonymous substitution in gE, a mutation that results in increased virulence in tissue culture and skin graft cultures (49) , and is also present in an independent VZV isolate from British Columbia (42) . In tissue culture, VZV is also extremely stable. Sequencing of VZV32 after 5, 22, and 72 passages has revealed significant sequence modification at only 3 locations. Three regions show expansion of DNA repeats: (i) an 8-bp region of ORF 11 at passage 5 was duplicated at passage 22 and maintained at passage 72; (ii) a 4-copy 54-bp repeat between ORFs 62 and 63 as well as the inverse ORFs 70 and 71 at passage 5 expanded to five copies by passage 22 and was maintained at passage 72; and (iii) one copy of an 18-bp duplication in ORF 22 at passage 5 was deleted by passage 22 and returned in passage 72. Notably, all of these variations occur in regions of the virus DNA that contain known sequence repeats, and none are contained within the origin of VZV DNA replication. Thus, while extended in vitro propagation produces local extension or retraction of known repeated DNA, our deep-sequence analysis of VZV-DEN09 showed a large deletion significantly affecting ORF 12 and 13 protein expression. In addition, specific areas (A, C, and C=) of overrepresented DNA, confirmed by multiple qPCR assays, were detected that most likely originated from fragments of virus DNA present in the infected cell nucleus but not contained in the virus genome or in VZV DNA prepared from E. coli as a stable bacterial artificial chromosome.
The 2,160-bp deletion in ORF 12 revealed by deep-sequence analysis represents the largest VZV DNA deletion identified to date in virus propagated under nonselective conditions. The 84.6-kDa tegument protein encoded by ORF 12 induces phosphorylation of ERK1/2 and Akt, which activate AP-1 and Akt pathways, respectively (46, 48) . AP-1 activation protects MeWo cells from staurosporine-induced apoptosis, and Akt activation increases levels of cyclin B1 and D3 to force cells from stationary phase and into M and S phases, respectively (46, 48) . Sequence analysis of the ORF 12 deletion within VZV-DEN09 showed the first 22 codons of ORF 12 were retained but that a new termination codon is formed from the fusion between codon 22 of ORF 12 with the initiation codon of ORF 13. This interesting arrangement would preserve the N-terminal 22 amino acids of ORF 12 but lack the gene's 3=-untranslated regulatory sequences. Our (48), indicated that ORF 12 was required for activation of the Akt pathway, since VZV-DEN09 infection failed to phosphorylate Akt. ORF 13 transcription also could be affected in VZV-DEN09-infected cells, since the 2,160-bp deletion removed the entire 241-bp ORF 12/13 intergenic region that presumably contains the regulatory sequences for ORF 13 transcription. Indeed, we found that while RNA mapping to ORF 13 was present (likely a result of a read-through event from fused ORF 12/13), no ORF 13 protein was made. The thymidylate synthetase (50) and is a prime site for targeted insertion of foreign genes (51, 52) . The nonessential nature of ORF 12 and ORF 13 proteins is echoed by our growth analysis, in which we did not observe a replication defect in HFL cells infected with VZV-DEN09. However, a slight decrease in replication was apparent in infected MeWo cells at later times postinfection. Since MeWo cells were derived from a malignant melanoma, these findings suggest that the ORF 12 and ORF 13 proteins serve different functions in normal and cancer cell lines. The VZV lytic transcriptome has been analyzed by PCR-based (53) and long oligonucleotide-based (54) arrays, by multiplex PCR (29) , and by next-generation cDNA sequencing (55) (56) (57) . While differences in transcript profiles are noted depending on cell type, time of harvest, and technique used, general themes emerge when the data are restricted to RNA-seq findings during lytic VZV infection. Combining published RNA-seq data derived from VZV-infected HFL cells or human neurons in culture with results in the present study showed individual differences in transcript abundance. For example, the five most abundant transcripts (in decreasing order) map to ORFs 57, 9, 68, 58, and 63 (55), ORFs 57, 49, 9, 68, and 67 (22) , and ORFs 9, 49, 63, 68, and 4 (this study); however, when virus gene classes are analyzed, all studies identify immediate-early transcripts as the most abundant, followed by late and early transcripts. Similarly, transcripts that regulate virus gene transcription are the most abundant, followed by transcripts encoding glycoproteins, nucleocapsid proteins, and, finally, proteins involved in virus DNA replication (Table 5 ). In addition to determining steady-state amounts of previously mapped virus genes, RNA-seq analysis can indicate the presence of novel virus transcriptional units. For example, RNA mapping to the unannotated 1.4-kbp region between VZV ORFs 60 and 61 has been detected by Northern blot (58) and array (53) analyses, and preliminary cloning results suggest extensive splicing of short segments into single polyadenylated virus transcripts within this region (unpublished data). Mapping our current RNA-seq data to this region revealed multiple short and low-abundance RNA segments on the opposite coding strand of ORFs 60 and 61 ( Fig. 11) . Overall, we have developed a technique to enrich low-abundance VZV DNA and cDNA in an unbiased manner; consequently, we identified a deletion in the coding region of a VZV gene which occurred through normal (no intentional selective pressure) in vitro propagation. Comparison of available RNA-seq data showed differences in individual gene transcript amounts but concordance at the level of gene groupings. Interestingly, transcripts mapping to immediate-early genes functionally identified as regulators of gene transcription were the most abundant transcriptional group detected during lytic infection in human fibroblasts or neurons harvested 2 days to 2 weeks postinfection, suggesting that the continuous presence of virus transactivators is required as the infection spreads throughout the culture.
The unique features of VZV propagated in vitro, as revealed by whole-genome analysis of VZV DNA and transcripts, raises several interesting questions. For example, how did the ORF 12 deletion develop, and what is its consequence on activation of cellular immediate-early response pathways? What mechanism leads to the overrepresented DNA that was identified by deep sequencing and confirmed by qPCR? Answers to these questions await further investigation.
In summary, the discovery of the ORF 12 deletion affecting ORF 12 and 13 protein production in the VZV-DEN09 strain of VZV32, revealed through whole-genome analysis, points to the need to authenticate the VZV genome when the virus is propagated in tissue culture. While this deletion appears to be restricted to VZV32, our data suggest that high passage can lead to changes in what is believed to be a stable VZV genome.
MATERIALS AND METHODS
Cells and virus. Human fetal lung fibroblasts (HFL; ATCC-CCL-153), MeWo malignant melanoma cells (59) , and MRC-5 human lung fibroblasts (ATCC CCL-171) were grown in Dulbecco's modified Eagle medium (Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT). Primary human brain vascular adventitia fibroblasts (HBVAFs) were grown in 2% FBS, 1% fibroblast growth serum, and 1% 100ϫ penicillin-streptomycin in basal fibroblast medium (Sciencell, Carlsbad, CA) as previously described (47) . After 24 h, the medium was changed to 0.1% FBS for 6 to 7 days to establish quiescence.
VZV32 (provided to R. J. Cohrs in 2009 by Charles Grose, University of Iowa) was propagated in MeWo cells for Ͼ50 passages and transferred as Dounce-homogenized cell-free virus (60) into HFL cells. This virus was designated VZV-DEN09 to uniquely identify the virus DNA and cDNA sequences analyzed in the current study. VZV32 (provided to K. S. Lee in 2013 by Charles Grose) was also propagated in a separate 
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